Arcus Biosciences, Inc.
NYSE · Healthcare · Pharmaceutical Preparations · Hayward, CA
RCUS chart
What traders are saying about $RCUS
Latest postsArcus Biosciences, Inc. news
- Arcus Biosciences, Inc. (RCUS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Arcus Biosciences (RCUS) Could Be 55% Undervalued As Third Quarter Losses Land
Simply Wall St ·
- Arcus Biosciences, Inc. (RCUS) stock price, news, quote and history
Yahoo Finance UK ·
- Wedbush Revises Best Ideas List After October Underperformance
Yahoo Finance ·
- Arcus Biosciences Stock Misses Revenue as Kidney Cancer Trial Readout Nears
Simply Wall St ·
- Arcus Biosciences stock trades at 17.69 US dollars after-hours
ad-hoc-news.de ·
- Leerink Partners maintains Arcus Biosciences at Outperform, raises price target to $49 from $46
TradingView ·
- Truist Securities maintains Arcus Biosciences at Buy, lowers price target to $40 from $41
TradingView ·
- Arcus Biosciences (RCUS) Stock May Be Fully Priced For Its Sales Potential
Simply Wall St ·
- Leerink Partners maintains Outperform on Arcus Biosciences, raises PT to $49
scanx.trade ·
- Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Arcus Biosciences, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
Arcus Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $33.0M | $51.0M | $37.0M | $38.0M |
| Net income | -$353.0M | -$283.0M | -$307.0M | -$267.0M |
| Diluted EPS | $-3.29 | $-3.14 | $-4.15 | $-3.71 |
| Total assets (year end) | $1.14B | $1.15B | $1.09B | $1.34B |
| Cash and equivalents (year end) | $222.0M | $150.0M | $127.0M | $206.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Arcus Biosciences, Inc.
- Ticker
- RCUS (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Hayward, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1724521
Frequently asked questions
What exchange is Arcus Biosciences, Inc. listed on?
Arcus Biosciences, Inc. trades on the NYSE under the ticker symbol RCUS.
What industry is Arcus Biosciences, Inc. in?
Arcus Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arcus Biosciences, Inc. headquartered?
Arcus Biosciences, Inc.'s business address on file with the SEC is in Hayward, CA.
When does Arcus Biosciences, Inc.'s fiscal year end?
Arcus Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Arcus Biosciences, Inc. report?
Arcus Biosciences, Inc. reported $33.0M in revenue for calendar year 2025, according to its SEC filings.